Orion Pharma Limited announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was BDT 2,394.716 million compared to BDT 1,537.001 million a year ago. Operating income was BDT 352.762 million compared to BDT 279.197 million a year ago. Net income was BDT 282.899 million compared to BDT 226.953 million a year ago. Basic earnings per share from continuing operations was BDT 1.21 compared to BDT 0.97 a year ago. For the half year, sales was BDT 5,323.719 million compared to BDT 3,763.556 million a year ago. Operating income was BDT 596.251 million compared to BDT 601.735 million a year ago. Net income was BDT 473.992 million compared to BDT 500.401 million a year ago. Basic earnings per share from continuing operations was BDT 2.03 compared to BDT 2.14 a year ago.